Evelo Biosciences Sees Unusually Large Options Volume (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) saw some unusual options trading activity on Wednesday. Stock traders acquired 1,885 put options on the stock. This represents an increase of approximately 1,101% compared to the typical volume of 157 put options.

Evelo Biosciences Price Performance

Evelo Biosciences stock opened at $0.00 on Thursday. The company has a market capitalization of $8,541.00, a PE ratio of 0.00 and a beta of 1.29. Evelo Biosciences has a 12-month low of $0.00 and a 12-month high of $0.76. The firm’s fifty day moving average is $0.01 and its 200 day moving average is $0.03.

Evelo Biosciences Company Profile

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.